XML 39 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2019
CNY (¥)
Dec. 31, 2018
CNY (¥)
Dec. 31, 2017
CNY (¥)
Cash flows from operating activities:        
Net income/(loss) $ (3,721) ¥ (25,911) ¥ 40,518 ¥ 7,923
Adjustments to reconcile net income to net cash used in operating activities:        
Depreciation of property and equipment 603 4,195 1,585 487
Amortization of intangible assets 5 36 18  
Sharebased compensation expenses 13,096 91,171 5,111 4,888
Allowance for doubtful accounts 1,437 10,004 2,570  
Exchange (gains) /losses 6 40 (275)  
Fair value changes of shortterm investments (264) (1,837) (3,498) (334)
Share of loss from equity method investments     2,794 549
Disposal gain on a subsidiary (1,645) (11,454)    
Rental, interest and payroll expense contributed by a shareholder 34 242 1,298 1,401
Content cost contributed by a noncontrolling shareholder     1,011  
Deferred income tax (443) (3,085) (252) (54)
Changes in operating assets and liabilities:        
Accounts receivable (52,540) (365,770) (121,538) (60,803)
Receivables due from related parties 920 6,403 (8,727) (2,134)
Prepayments and other current assets (4,959) (34,522) (6,950) (5,231)
Accounts payable 17,113 119,135 9,779 10,491
Salary and welfare payables 2,092 14,561 24,619 9,899
Taxes payable 2,647 18,428 7,421 9,157
Deferred revenue 565 3,934 681 3,546
Amounts due to related parties (284) (1,979) 1,181 798
Accrued liabilities and other payables 2,509 17,472 (2,944) 7,973
Net cash used in operating activities (22,829) (158,937) (45,598) (11,444)
Cash flows from investing activities:        
Purchase of property and equipment (666) (4,639) (16,402) (392)
Purchase of intangible assets (20) (137) (273)  
Purchase of shortterm investments (117,419) (817,450) (544,601) (130,000)
Proceeds from maturities of shortterm investments 126,171 878,376 504,982 28,000
Investment in equity method investment (6,093) (42,417)   (3,500)
Net cash paid upon disposal of a subsidiary (575) (4,005)    
Cash received from disposal of a equity investee 23 157    
Net cash (used in)/provided by investing activities 1,421 9,885 (56,294) (105,892)
Cash flows from financing activities:        
Proceeds from initial public offering, net of issuance costs 15,663 109,045    
Proceeds from loans provided by a third party 1,187 8,266    
Repayments of loans provided by a third party (1,219) (8,483)    
Proceeds from loans provided by a shareholder       8,500
Repayments of loans provided by a shareholder     (979) (7,521)
Capital injection from shareholders       10,000
Proceeds from issuance of Series C1 preferred shares     100,000 152,000
Proceeds from issuance of Series D preferred shares, net of issuance cost 24,383 169,750    
Share repurchase (335) (2,333)    
Cash paid to acquire a non-controlling interest (690) (4,803)    
Proceeds from issuance of convertible redeemable preferred shares to noncontrolling shareholders     5,695  
Capital injection from non-controlling interest shareholders 990 6,895    
Net cash provided by financing activities 39,979 278,337 104,716 162,979
Effect of exchange rate changes on cash, cash equivalents and restricted cash held in foreign currencies (54) (376) 501  
Net increase in cash, cash equivalents and restricted cash 18,517 128,909 3,325 45,643
Cash, cash equivalents and restricted cash at beginning of the year 7,034 48,968 45,643  
Cash, cash equivalents and restricted cash at end of the year 25,551 177,877 48,968 45,643
Supplemental disclosures of cash flow information:        
Cash paid for income taxes, net of tax refund (2,519) (17,538) (11,944) (313)
Cash paid for interest expense (11) (78) (92) (6)
Supplemental schedule of noncash investing and financing activities:        
Property and equipment purchases financed by other payable 18 122 123  
Rental, interest and payroll expense contributed by a shareholder 34 242 1,298 1,401
Content cost contributed by a noncontrolling shareholder     1,011  
Accretions of convertible redeemable preferred shares to redemption value 64,513 449,130 120,060 2,834
Accretion on redeemable noncontrolling interests to redemption value 260 1,808 ¥ 1,025 ¥ 0
Re-designation of Series A-1 into Series B-3 convertible redeemable preferred shares 3,848 26,787    
Re-designation of ordinary shares into Series B-3 convertible redeemable preferred shares 5,917 41,196    
Re-designation of ordinary shares into Series B-4 convertible redeemable preferred shares 5,146 35,822    
Re-designation of ordinary shares into Series A-1, A-2, B-1, B-2, B-3, and issuance of Series A-1, A-2, B-1, B-2, B-3 preferred shares 44,526 309,984    
Re-designation of ordinary shares into Series C-2 convertible redeemable preferred shares 5,311 36,977    
Re-designation of Preferred Shares into Class A ordinary shares upon initial public offering 269,793 1,878,247    
Accrued listing expense for the initial public offering $ 3,276 ¥ 22,807